MRX-1043

N/A

Report date: 2025/01/26 15:38:16
NME

Base Information

Drug NameMRX-1043
Drug Alias NameRyNOs (Myotherix)nitric oxide-donating ryanodine calcium release channel stabilizers (Myotherix)MRX-1043
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRyanodine receptor calcium release channel modulators
TargetsRyanodine receptor calcium release channel
Therapy Area/IndicationsNeuromuscular DiseasesMuscular Dystrophy, Duchenne
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMyoTherix Inc
China Registration ClassN/A

Develop Information

Active CompaniesMyoTherix Inc
Inactive CompaniesN/A
Active IndicationsNeuromuscular DiseasesMuscular Dystrophy, Duchenne
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A